Alyeska Investment Group
DCPH

Alyeska Investment Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Alyeska Investment Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,400
Closed -$315K – 645
2023
Q1 		$315K Buy
+20,400
New +$341K ﹤0.01% 424
2021
Q3 		– Sell
-142,932
Closed -$5.23M – 825
2021
Q2 		$5.23M Sell
142,932
-25,000
-15% -$968K 0.06% 330
2021
Q1 		$7.53M Buy
167,932
+51,339
+44% +$2.39M 0.1% 251
2020
Q4 		$6.65M Sell
116,593
-35,376
-23% -$2.1M 0.09% 239
2020
Q3 		$7.8M Buy
151,969
+70,523
+87% +$3.45M 0.12% 212
2020
Q2 		$4.86M Buy
81,446
+56,446
+226% +$3.02M 0.07% 271
2020
Q1 		$1.03M Buy
+25,000
New +$1.39M 0.02% 292
2019
Q4 		– Sell
-162,993
Closed -$5.53M – 507
2019
Q3 		$5.53M Buy
162,993
+23,802
+17% +$705K 0.08% 217
2019
Q2 		$3.14M Buy
139,191
+85,910
+161% +$2.01M 0.04% 276
2019
Q1 		$1.24M Sell
53,281
-39,719
-43% -$1.04M 0.02% 306
2018
Q4 		$1.95M Sell
93,000
-48,607
-34% -$1.19M 0.03% 286
2018
Q3 		$5.48M Hold
141,607
– – 0.06% 233
2018
Q2 		$5.57M Buy
141,607
+66,278
+88% +$1.95M 0.05% 267
2018
Q1 		$1.51M Sell
75,329
-25,086
-25% -$635K 0.01% 369
2017
Q4 		$2.28M Sell
100,415
-3,235
-3% -$63.3K 0.02% 325
2017
Q3 		$1.97M Buy
+103,650
New +$1.9M 0.01% 365

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group's DCPH Position: Q2 2023 in Review

Alyeska Investment Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2023, closing a stake of 20,400 shares — an estimated $315K sold.

Alyeska Investment Group first reported a position in DCPH in Q3 2017 and held it in 16 quarters. The position peaked at $7.8M in Q3 2020. 145 funds tracked by Wall St. Rank hold DCPH as of Q2 2023.

  • Alyeska Investment Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 20,400 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $315K.
  • Alyeska Investment Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 16 quarters.
  • Alyeska Investment Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $7.8M in Q3 2020.
  • 145 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Alyeska Investment Group's 13F filing for Q2 2023, filed 14 Aug 2023.